HIG
56
-7
IRM
41
7
XOM
64
8
DE
48
5
MOS
26
-3
MPC
50
-4
ROP
50
5
UPS
40
2
GD
59
2
ORLY
49
-3
ZBH
47
-12
FRT
58
2
STI
13
-2
ORCL
32
3
VMC
59
3
UAL
87
5
CAH
58
-3
PHM
52
-7
CME
49
-3
GT
55
9
HIG
56
-7
IRM
41
7
XOM
64
8
DE
48
5
MOS
26
-3
MPC
50
-4
ROP
50
5
UPS
40
2
GD
59
2
ORLY
49
-3
ZBH
47
-12
FRT
58
2
STI
13
-2
ORCL
32
3
VMC
59
3
UAL
87
5
CAH
58
-3
PHM
52
-7
CME
49
-3
GT
55
9
Financhill
Back

Viking Therapeutics, Inc. 10K Form

Sell
45

VKTX
Viking Therapeutics, Inc.

Last Price:
$38.53
Seasonality Move:
78.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-94M
Price / Cash Flow: 0
Annual Sales: $6.34
Price / Book: 5.61

Profitability

EPS (TTM): -2.11830
Net Income (TTM): $-237.4M
Gross Margin: $-346K
Return on Equity: -28.62%
Return on Assets: -27.73%

Viking Therapeutics, Inc. Earnings Forecast

Key Viking Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 13 years have been positive in 4 years.

Viking Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 28.34
Quick Ratio: 27.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
45
Viking Therapeutics, Inc. (VKTX) is a Sell

Is Viking Therapeutics, Inc. a Buy or a Sell?